GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (FRA:5HZ1) » Definitions » Gross-Profit-to-Asset %

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Gross-Profit-to-Asset % : 8.39% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Hangzhou Tigermed Consulting Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was €321.0 Mil. Hangzhou Tigermed Consulting Co's average Total Assets over the quarter that ended in Mar. 2024 was €3,826.7 Mil. Therefore, Hangzhou Tigermed Consulting Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 8.39%.


Hangzhou Tigermed Consulting Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Gross-Profit-to-Asset % Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.32 11.12 10.97 10.84 9.72

Hangzhou Tigermed Consulting Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.30 10.33 10.67 7.62 8.39

Competitive Comparison of Hangzhou Tigermed Consulting Co's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Gross-Profit-to-Asset % falls into.



Hangzhou Tigermed Consulting Co Gross-Profit-to-Asset % Calculation

Hangzhou Tigermed Consulting Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=365.83/( (3716.383+3811.832)/ 2 )
=365.83/3764.1075
=9.72 %

Hangzhou Tigermed Consulting Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=320.976/( (3811.832+3841.501)/ 2 )
=320.976/3826.6665
=8.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Hangzhou Tigermed Consulting Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (FRA:5HZ1) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Headlines

No Headlines